| The JCA Mauvernay Award / Japan |
|
The 2010 edition of the JCA Mauvernay Award will be granted on 24th September, during the 69th Annual Meeting of Japanese Cancer Association to be held at Osaka International Convention Center from 22 to 24 September 2010. The Award, funded by Debiopharm and organised by the JCA, aims at recognising cutting-edge oncology research in both the fundamental and the clinical aspects and to encourage Japanese researchers to make their work available to other parts of the world. Potential Candidates must be researchers and members of the JCA who have been recommended by the councillors of the JCA and who have achieved excellent results in the fields of either basic or clinical research in oncology. The JCA counts about 17,000 members, all from universities, governmental and private research organisations throughout Japan. Each year, the Award Committee selects nominee(s) for the JCA-Mauvernay Award from fundamental cancer research and/or clinical cancer research. Nominees:2009
2008
Japanese Cancer Association and Debiopharm Honour Japanese Research - Professors Ichijo and Mano receive 2008 JCA-Mauvernay Award 2007
Japanese Scientists Receive JCA-Mauvernay Award 2007 2006
2005
|



